DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Virtual Booth

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

2DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Alm301, 1313439-71-2, Vad044, Vad-044, K2us8hw4tq, Chembl5314970

Molecular Formula

C₂₅H₂₅N₃O₃

Molecular Weight

415.5 g/mol

InChI Key

BPHCAPAOSHZYJY-UHFFFAOYSA-N

FDA UNII

K2US8HW4TQ

VAD-044 is an allosteric AKT inhibitor developed by Vaderis Therapeutics AG. It is being investigated for the treatment of Hereditary Hemorrhagic Telangiectasia.

1 2D Structure

VAD044

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

6-[4-(1-amino-3-hydroxycyclobutyl)phenyl]-1-ethyl-7-phenylpyrido[2,3-b][1,4]oxazin-2-one

2.1.2 InChI

InChI=1S/C25H25N3O3/c1-2-28-21-12-20(16-6-4-3-5-7-16)23(27-24(21)31-15-22(28)30)17-8-10-18(11-9-17)25(26)13-19(29)14-25/h3-12,19,29H,2,13-15,26H2,1H3

2.1.3 InChI Key

BPHCAPAOSHZYJY-UHFFFAOYSA-N

2.2 Other Identifiers

2.2.1 UNII

K2US8HW4TQ

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. Alm301

2. 1313439-71-2

3. Vad044

4. Vad-044

5. K2us8hw4tq

6. Chembl5314970

7. Schembl12506659

8. Schembl14917320

9. Ex-a7217

10. At43335

11. Da-60932

12. Ms-27212

13. Hy-151504

14. Cs-0614399

15. 1h-pyrido[2,3-b][1,4]oxazin-2(3h)-one, 6-[4-(cis-1-amino-3-hydroxycyclobutyl)phenyl]-1-ethyl-7-phenyl-

2.4 Create Date

2012-11-30

3 Chemical and Physical Properties

Molecular Formula	C₂₅H₂₅N₃O₃
Molecular Weight	415.5 g/mol
XLogP3	2.6
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	5
Rotatable Bond Count	4
Exact Mass	g/mol
Monoisotopic Mass	g/mol
Topological Polar Surface Area	88.7
Heavy Atom Count	31
Formal Charge	0
Complexity	638
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1